Arrhythmias, sudden death and syncope in hypertensive cardiovascular disease

Cardiac Electrophysiology Review

Volumn 6, Issue 1-2, 2002, Pages 36-41

  Moncrieff, Joanne ^a   McGavigan, Andrew D ^a   Dunn, Francis G ^a  

^a STOBHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; COLLAGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; MATRIX METALLOPROTEINASE; PLACEBO; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; HEART ATRIUM ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HUMAN; HYPERTENSION; MALE; MORTALITY; MUSCLE ACTION POTENTIAL; NONHUMAN; ORTHOSTATIC HYPOTENSION; RAT; RISK ASSESSMENT; SUDDEN DEATH; SYNCOPE;

ARRHYTHMIA; DEATH, SUDDEN, CARDIAC; ELECTROPHYSIOLOGY; HUMANS; HYPERTENSION; SYNCOPE;

EID: 0036193255     PISSN: 13852264     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1017974803000     Document Type: Article

References (46)

1. Electro-cardiographic left ventricular hypertrophy and risk of coronary heart disease: The Framingham Study
2. Relation between extent of left ventricular hypertrophy and occurrence of sudden cardiac death in hypertrophic cardiomyopathy
3. Arrhythmia in hypertrophic cardiomyopathy: Exercise and 48 hour ambulatory electrocardiographic assessment with and without beta adrenergic blocking therapy
4. Hypertension and sudden death; increased ventricular ectopic activity in left ventricular hypertrophy
5. Risk of ventricular arrhythmias in left ventricular hypertrophy; The Framingham Heart Study
6. Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy
7. Impact of left ventricular hypertrophy on ventricular arrhythmias in the absence of coronary artery disease
8. The electrocardiogram in prediction of sudden death: The Framingham experience
9. Significance of ventricular arrhythmias in systemic hypertension with left ventricular hypertrophy
10. Symptomatic and silent ischaemia in hypertensive patients with left ventricular hypertrophy
11. Increased prevalence of cardiac arrhythmias and transient episodes of myocardial ischaemia in hypertensives with left ventricular hypertrophy but without coronary artery disease
12. Ventricular arrhythmias in untreated newly presenting hypertensive patients with matched normal population
13. Atrial arrhythmias in hypertension
14. Cardiac arrest recorded on ambulatory electrocardiograms
15. Ambulatory electrocardiographic recordings at the time of fatal cardiac arrest
16. Sudden death during long term ambulatory ECG
17. Ambulatory sudden cardiac death: Mechanisms of production of fatal arrhythmia on the basis of data from 157 cases
18. Prevalence and natural history of electrocardiographic left ventricular hypertrophy
19. Prognostic implications of the echocardiographically determined left ventricular mass in the Framingham Heart study
20. Transient ischaemic attack related syncope
21. Orthostatic hypotension with syncope. A problem of antihypertensive therapy in the aged
22. Cellular electrophysiology in cardiac hypertrophy and failure
23. Calcium currents in normal and hypertrophied isolated feline ventricular myocytes
24. Outward currents in normal and hypertrophied feline ventricular myocytes
25. Afterpotentials and triggered activity in hypertrophied myocardium from rats with renal hypertension
26. Non-uniform electrophysiological properties and electronic interaction in hypertrophied rat myocardium
27. The discontinuous nature of propagation in normal canine cardiac muscle; evidence for recurrent discontinuities of intracellular resistance that affect membrane currents
28. Effect of left ventricular hypertrophy and its regression on ventricular electrophysiology and vulnerability to inducible arrhythmia in the feline heart
29. Regression of left ventricular hypertrophy with captopril restores normal ventricular action potential duration, dispersion of refractoriness and vulnerability to inducible ventricular fibrillation
30. QT dispersion in essential hypertension
31. Prognostic values of arrhythmogenic markers in systemic hypertension
32. Predictors of death in hypertensive left ventricular hypertrophy
33. Is ventricular wall stress rather than left ventricular hypertrophy an important contributory factor to sudden cardiac death
34. Electrophysiologic consequences of chronic experimentally induced left ventricular pressure overload
35. Recent advances in the identification of patients at risk of ventricular tachyarrhythmias: Role of ventricular late potentials
36. Biochemical markers of tissue fibrosis predict diastolic dysfunction in patients with hypertension
37. Blood pressure control in hypertension causing a reduction in Tissue Inhibitor of Matrix Metalloproteinase-1 (TIMP-1) and improved diastolic function
38. Prevalence of circadian variations and spontaneous variability of cardiac disorders and ECG changes suggestive of myocardial ischaemia in systemic arterial hypertension
39. Pathophysiologic assessment of left ventricular hypertrophy and strain in asymptomatic patients with essential hypertension
40. Prevalence and prognostic significance of exercise induced myocardial ischaemia detected by thallium scintigraphy and electrocardiography in asymptomatic volunteers
41. What is the role of silent coronary artery disease and left ventricular hypertrophy in the genesis of ventricular arrhythmias in men with essential hypertension
42. Ventricular arrhythmia in hypertensive heart disease with and without heart failure
43. Hypertension and sudden death: Disparate effects of calcium entry blocker and diuretic therapy on cardiac dysrhtyhmias
44. Prevalence of ventricular ectopic activity after left ventricular mass regression
45. Effects of intensive blood pressure lowering and low dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
46. Effect of ecainide and flecainide on mortality in a randomised trial of arrhythmia suppression after myocardial infraction